Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-26078.89%
operating margin TTM
-28346.67%
revenue TTM
91.96 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.12 |
| peg ratio | -0.02 |
| price to book ratio | 11.41 |
| price to sales ratio | 293.50 |
| enterprise value multiple | -2.96 |
| price fair value | 11.41 |
profitability ratios | |
|---|---|
| gross profit margin | 538.89% |
| operating profit margin | -28346.67% |
| pretax profit margin | -26078.89% |
| net profit margin | -26078.89% |
| return on assets | -51.66% |
| return on equity | -218.67% |
| return on capital employed | -66.98% |
liquidity ratios | |
|---|---|
| current ratio | 5.89 |
| quick ratio | 5.89 |
| cash ratio | 5.73 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | -6,112.59 |
| cash conversion cycle | 6,112.59 |
| receivables turnover | 0.00 |
| payables turnover | -0.06 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.66 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.40 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -15.06 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.74 |
| cash per share | 1.35 |
| operating cash flow per share | -0.73 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -15.06 |
| short term coverage ratios | -31.17 |
| capital expenditure coverage ratio | -215.81 |
Frequently Asked Questions
When was the last time Actinium Pharmaceuticals, Inc. (AMEX:ATNM) reported earnings?
Actinium Pharmaceuticals, Inc. (ATNM) published its most recent earnings results on 08-05-2026.
What is Actinium Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Actinium Pharmaceuticals, Inc. (AMEX:ATNM)'s trailing twelve months ROE is -218.67%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Actinium Pharmaceuticals, Inc. (ATNM) currently has a ROA of -51.66%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ATNM's net profit margin stand at?
ATNM reported a profit margin of -26078.89% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ATNM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.89 in the most recent quarter. The quick ratio stood at 5.89, with a Debt/Eq ratio of 0.66.